IFNG and neoplasm: ILC1s: ILC1s, traditionally considered less cytotoxic than NK cells but with robust cytokine‐producing functions, can contribute to anti‐tumour immunity through supporting dendritic cell (DC) activation and promoting T cell responses, particularly through interferon (IFN)γ production [81].